Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Defense Verdict Returned in NEC Lawsuit Against Abbott, Mead Johnson in Missouri State Court Verdict comes after two previous juries ordered Abbott Laboratories and Mead Johnson to pay millions of dollars in damages to families of children who developed NEC from Similac or Enfamil. November 1, 2024 Irvin Jackson Add Your Comments A Missouri jury has found that the makers of Similac and Enfamil are not liable for a newborn’s development of necrotizing enterocolitis (NEC), in the third trial involving claims that Abbott Laboratories and Mead Johnson have failed to warn families that their infant formula products may increase the risk of devastating injuries for premature babies. The defense verdict was returned after a five week trial involving a NEC lawsuit brought by Elizabeth Whitfield, which was being closely watched, since the two prior cases to go before juries resulted in combined judgments of more than $555 million against the two manufacturers. NEC is a severe gastrointestinal disease that occurs when harmful bacteria breaches the walls of the intestines, causing portions of the tissue to become inflamed or die. Although cow’s milk-based formulas like Similac and Enfamil have been marketed for decades as safe to use among premature infants, there is now increasing evidence that these vulnerable children face an unreasonable risk of developing NEC from these kinds of formulas, as opposed to a mother’s breast milk or human donor milk. These three trials come as about 1,000 other Similac lawsuits and Enfamil lawsuits continue to move forward in state and federal courts nationwide, all involving similar allegations that the manufacturers withheld critical information from families and the medical community for decades. BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Whitfield’s lawsuit sought damages for injuries experienced by her son, who was born in 2017 and developed NEC after being fed Abbott Laboratories’ Similac and Mead Johnson’s Enfamil formulas while still in the hospital. As a result, the child still suffers severe complications, including a shortened bowel, which makes absorbing nutrients more difficult. After considering evidence presented in the case, a St. Louis, Missouri jury handed down a defense verdict on Thursday, indicating that the two companies should not be held responsible for the injuries. The manufacturers argued at trial that the child was born extremely ill, and at under 28 weeks gestation, indicating that other health problems and antibiotic treatments he received for anemia could have contributed to his development of NEC. The defense verdict comes after two prior state court juries came to very different conclusions in cases that went to trial earlier this year. In March 2024, an Illinois jury ordered Mead Johnson to pay $60 million in damages in an Enfamil lawsuit brought by Jasmine Watson. Following over four weeks of testimony, it took the jury only four hours to reach a verdict, awarding $25 million more in damages than Watson’s attorneys had asked for. In July 2024, a separate jury in St. Louis ordered Abbott Laboratories to pay $495 million in a Similac lawsuit, including a massive punitive damages award intended to punish the manufacturer for disregarding the health and safety of premature infants and families. November 2024 Infant Formula NEC Lawsuits Update The state court trial comes as hundreds of other claims continue to move forward in the federal court system, where they have been centralized as part of a federal MDL (multidistrict litigation) in the Northern District of Illinois since 2022. As part of the management of the federal litigation, U.S. District Judge Rebecca R. Pallmeyer previously established a “bellwether” program, where a group of representative claims have been selected for a series of early trial dates, which are designed to help the parties gauge how juries will respond to certain evidence and testimony that will be repeated throughout the litigation. The parties selected four baby formula NEC lawsuit bellwether candidates in October 2023, and have been preparing each of the claims for trial over the past year. The first MDL trial dates for the NEC lawsuits are expected to begin in May 2025, and will be spaced about 12 weeks apart. While the outcomes of these early trial dates do not have any binding impact on lawsuits being pursued by other families, the average lawsuit payouts may have a substantial impact on the amount that Abbott and Mead Johnson could be required to pay in NEC settlements to avoid hundreds of additional claims going before juries. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Abbott Laboratories, Enfamil, Infant Formula, Mead Johnson, Missouri, Necrotizing Enterocolitis, Preterm Birth, Similac Find Out If You Qualify for Infant Formula NEC Compensation More Baby Formula Lawsuit Stories Second NEC Baby Formula Bellwether Trial Will Not Move Forward July 29, 2025 Similac NEC Settlement Talks Result in MDL Census Order for Filed and Unfiled Claims July 24, 2025 Mead Johnson Must Face Enfamil NEC Lawsuit in Missouri State Court July 8, 2025 0 Comments NameThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: yesterday) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025) Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (Posted: 2 days ago) Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation. MORE ABOUT: OZEMPIC LAWSUITReports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)Study Raises New Questions Over Ozempic Hair Loss Risks (09/26/2025)Mounjaro Side Effects Led to Emergency Surgery, Lawsuit Alleges (09/24/2025) Over 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (Posted: 3 days ago) A federal judge has called for more coordination between state and federal courts handling Depo shot lawsuits claiming the contraceptive causes brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)Judge To Hear Depo-Provera Lawsuit Preemption Arguments on Monday (09/26/2025)Link Between Depo-Provera and Meningioma Brain Tumors Ignored by Pfizer, Plaintiffs Indicate (09/22/2025)
Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: yesterday) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)
Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (Posted: 2 days ago) Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation. MORE ABOUT: OZEMPIC LAWSUITReports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)Study Raises New Questions Over Ozempic Hair Loss Risks (09/26/2025)Mounjaro Side Effects Led to Emergency Surgery, Lawsuit Alleges (09/24/2025)
Over 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (Posted: 3 days ago) A federal judge has called for more coordination between state and federal courts handling Depo shot lawsuits claiming the contraceptive causes brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)Judge To Hear Depo-Provera Lawsuit Preemption Arguments on Monday (09/26/2025)Link Between Depo-Provera and Meningioma Brain Tumors Ignored by Pfizer, Plaintiffs Indicate (09/22/2025)